The World of Health & Medicine News

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal

The World Health Organization chief said on Thursday that he was still hoping the U.S. administration would reconsider its decision to withdraw from the organisation next month, saying that its exit would be a loss for the world.

In one of his first acts as U.S. president, Donald Trump signed the order to withdraw, saying the global health agency had mishandled the COVID-19 pandemic and was too close to China. It will take effect on Jan. 22, 2026.

The decision has raised concerns about global cooperation on any future outbreaks which the WHO helps coordinate through a series of international health regulations.

“There are things you can get only at the WHO and nowhere else. These issues are health security issues … and that’s why we were asking the U.S. to reconsider, because the world can only be secure if we are all in the same platform,” said WHO Director-General Tedros Adhanom Ghebreyesus in response to a reporter’s question about the withdrawal.

“Their absence from WHO is going to be a lose-lose, they will lose because of that. The rest of the world will also lose.”

Tedros said U.S. criticisms of the organisation were unwarranted since it was addressing them including through cost-cutting reforms. On the accusation of the mismanagement of the pandemic, he said lessons had been learned.

spot_img

Explore more

spot_img

FDA approves first new antibiotics to treat gonorrhea in decades, with...

FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance  The U.S. health regulator on Friday approved Innoviva's oral...

US FDA Approves First At-Home Device for Depression

US FDA Approves First At-Home Device for Depression The U.S. Food and ‌Drug ​Administration has approved Flow Neuroscience's ‌at-home brain stimulation device to treat depression,...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of...

FDA approves first gene therapy for rare immune disorder

FDA approves first gene therapy for rare immune disorder The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy...

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS Stopping GLP-1 weight-loss drugs before pregnancy appears to increase the risk of complications and preterm delivery, a new...

US FDA approves first drug under new fast-track review program

US FDA approves first drug under new fast-track review program The U.S. Food and Drug Administration approved on Tuesday the ​first drug under its new...

Global leaders commit $1.9 billion to eradicate polio amid funding cuts

Global leaders commit $1.9 billion to eradicate polio amid funding cuts Global leaders pledged $1.9 billion to advance polio eradication on Monday, accelerating efforts to...

US FDA qualifies first AI tool to help speed liver disease...

US FDA qualifies first AI tool to help speed liver disease drug development The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed...